N@N

FRISCO, TEXAS--(Marketwire - Feb. 17, 2011) - Today it is announced that Stanford Management Ltd. has changed its name to Allezoe Medical Holdings, Inc. (OTCBB:ALZM), effective today. Allezoe Medical Holdings ("Allezoe") common shares will now trade on the OTC Bulletin Board under the new ticker symbol ALZM.

The name change is the first step in Allezoe's strategy to develop a portfolio of companies in the medical device, solutions, and services arena.

On January 24, Stanford Management Ltd. (now Allezoe) filed a Form 8-K stating that it would acquire all of the issued and outstanding stock of Organ Transport Systems, Inc. Organ Transport Systems ("OTS") is a biomedical company engaged in developing, patenting, and commercializing portable hypothermic, oxygenated preservation and transport technology for human organs. OTS plans to redefine human organ transplantation through better preservation, with its LifeCradle® product line.

Organ Transport Systems will become the anchor company for Allezoe, which plans to seek out other groundbreaking medical technology and services for inclusion in its portfolio.

FORWARD LOOKING STATEMENT

This announcement is not an offer to sell any Allezoe ("ALZM") or related securities. Offers for any given security are made only through applicable offering circulars and related documents filed with the SEC pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934. Certain statements contained herein and subsequent oral statements made by and on behalf of ALZM may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and includes, without limitation, statements regarding ALZM's plan of business operations, product research and development activities, anticipated revenues and expenses and potential contractual arrangements and obligations. Also, our management may make forward-looking statements orally to investors, analysts, the media and others. Forward-looking statements express our expectations or predictions of future events or results. They are not guarantees and are subject to many risks and uncertainties. There are a number of factors beyond our control that could cause actual events or results to be significantly different from those described in the forward-looking statements. Any or all of our forward-looking statements in this report or in any other public statements we make may turn out to be wrong. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise.